GLP-1 Receptor Agonists and Blood Pressure: A State-of-the-Art Review of Mechanisms, Evidence, and Clinical Implications. [PDF]
Moiz A +3 more
europepmc +1 more source
Medication time of metformin and sulfonylureas and incidence of cardiovascular diseases and mortality in type 2 diabetes: a pooled cohort analysis. [PDF]
Bahardoust M +4 more
europepmc +1 more source
Two for the heart: Dutch Pharmacogenetic Working Group prescribing guidance on statins and sulfonylureas to reduce cardiometabolic risk. [PDF]
David SP.
europepmc +1 more source
Recent Advances in Glimepiride Solubility Improvement: A Focus on Formulation Technologies - A Narrative Review. [PDF]
Fiftianingrum V +3 more
europepmc +1 more source
Journal of Internal Medicine, Volume 299, Issue 6, Page 776-780, June 2026.
Vincent Ka Chun Yan +6 more
wiley +1 more source
Pyroptosis in epilepsy: from pathophysiological mechanisms to therapeutic strategies. [PDF]
Chen Q +4 more
europepmc +1 more source
Intracellular Pharmacokinetics of Antidiabetic Drugs: A Focused Narrative Review of Subcellular Distribution (2015-2025). [PDF]
Bafail DA.
europepmc +1 more source
A plasma N-acetyl amino acid panel for type 2 diabetes discrimination built by targeted LC-MS/MS: A case-control study. [PDF]
Ding S +7 more
europepmc +1 more source
Sulfonylurea drugs for people with severe hemispheric ischemic stroke. [PDF]
Fan L +5 more
europepmc +1 more source

